Moemen Eltelbany
Research Subjects
Moemen Eltelbany has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Alexander G. Truesdell
Virginia Heart/Inova Schar Heart and Vascular, Falls Church, Virginia
1 shared publication - Carolyn Rosner
Department of Cardiovascular Disease, Inova Schar Heart and Vascular, Inova Fairfax Medical Campus, Falls Church, Virginia, USA
1 shared publication - Lindsey A. Cilia
Virginia Heart Falls Church Virginia USA
1 shared publication - Michael Megaly
Division of Cardiovascular Disease Integris Health Heart Hospital Oklahoma City Oklahoma USA
1 shared publication - Rhian Davies
WellSpan York Hospital, York, Pennsylvania, USA
1 shared publication
Latest Publications
- Open Access
- 4 April 2023
- Published by Radcliffe Medical Media Ltd in US Cardiology Review
- Vol. 17
Mechanical Circulatory Support for Complex High-risk Percutaneous Coronary Intervention
Technological and procedural innovations presently permit the safe and effective performance of increasingly complex percutaneous coronary interventions, while new mechanical circulatory support devices offer circulatory and ventricular support to patients with severely reduced left ventricular systolic function and deranged cardiovascular hemodynamics. Together, these advances now permit the application of complex percutaneous coronary interventions to higher-risk patients who might otherwise be left untreated. Increasing observational data support the use of mechanical circulatory support in appropriate complex and high-risk patients as part of a larger multidisciplinary heart team treatment plan. In-progress and upcoming randomized clinical trials may provide higher-quality evidence to better guide management decisions in the near future.
- 4 April 2023
- Published by Radcliffe Medical Media Ltd in US Cardiology Review
- Vol. 17
Open AccessMechanical Circulatory Support for Complex High-risk Percutaneous Coronary Intervention
Technological and procedural innovations presently permit the safe and effective performance of increasingly complex percutaneous coronary interventions, while new mechanical circulatory support devices offer circulatory and ventricular support to patients with severely reduced left ventricular systolic function and deranged cardiovascular hemodynamics. Together, these advances now permit the application of complex percutaneous coronary interventions to higher-risk patients who might otherwise be left untreated. Increasing observational data support the use of mechanical circulatory support in appropriate complex and high-risk patients as part of a larger multidisciplinary heart team treatment plan. In-progress and upcoming randomized clinical trials may provide higher-quality evidence to better guide management decisions in the near future.